We use cookies to understand how you use our site and to improve your experience.
This includes personalizing content and advertising.
By pressing "Accept All" or closing out of this banner, you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties.
You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
In addition, whether you "Accept All," Deny Optional," click the X or otherwise continue to use the site, you accept our Privacy Policy and Terms of Service, revised from time to time.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Cardinal Health (CAH) Stock Moves -1.47%: What You Should Know
Read MoreHide Full Article
In the latest close session, Cardinal Health (CAH - Free Report) was down 1.47% at $207.83. The stock exceeded the S&P 500, which registered a loss of 1.51% for the day. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 2.01%.
The prescription drug distributor's shares have seen a decrease of 5.32% over the last month, surpassing the Medical sector's loss of 7.54% and falling behind the S&P 500's loss of 3.63%.
The investment community will be closely monitoring the performance of Cardinal Health in its forthcoming earnings report. The company is forecasted to report an EPS of $2.8, showcasing a 19.15% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $62.42 billion, up 13.74% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $10.31 per share and a revenue of $259.27 billion, signifying shifts of +25.12% and +16.48%, respectively, from the last year.
It is also important to note the recent changes to analyst estimates for Cardinal Health. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.04% higher within the past month. Cardinal Health is currently a Zacks Rank #2 (Buy).
From a valuation perspective, Cardinal Health is currently exchanging hands at a Forward P/E ratio of 20.45. This expresses a premium compared to the average Forward P/E of 15.72 of its industry.
Also, we should mention that CAH has a PEG ratio of 1.36. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.77.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 68, putting it in the top 28% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report
predicting the 7 stocks that will soar highest in the coming month.
View the Zacks #1 Rank List
Image: Bigstock
Cardinal Health (CAH) Stock Moves -1.47%: What You Should Know
In the latest close session, Cardinal Health (CAH - Free Report) was down 1.47% at $207.83. The stock exceeded the S&P 500, which registered a loss of 1.51% for the day. Elsewhere, the Dow saw a downswing of 0.97%, while the tech-heavy Nasdaq depreciated by 2.01%.
The prescription drug distributor's shares have seen a decrease of 5.32% over the last month, surpassing the Medical sector's loss of 7.54% and falling behind the S&P 500's loss of 3.63%.
The investment community will be closely monitoring the performance of Cardinal Health in its forthcoming earnings report. The company is forecasted to report an EPS of $2.8, showcasing a 19.15% upward movement from the corresponding quarter of the prior year. Our most recent consensus estimate is calling for quarterly revenue of $62.42 billion, up 13.74% from the year-ago period.
For the annual period, the Zacks Consensus Estimates anticipate earnings of $10.31 per share and a revenue of $259.27 billion, signifying shifts of +25.12% and +16.48%, respectively, from the last year.
It is also important to note the recent changes to analyst estimates for Cardinal Health. Such recent modifications usually signify the changing landscape of near-term business trends. Therefore, positive revisions in estimates convey analysts' confidence in the business performance and profit potential.
Empirical research indicates that these revisions in estimates have a direct correlation with impending stock price performance. Investors can capitalize on this by using the Zacks Rank. This model considers these estimate changes and provides a simple, actionable rating system.
The Zacks Rank system, ranging from #1 (Strong Buy) to #5 (Strong Sell), possesses a remarkable history of outdoing, externally audited, with #1 stocks returning an average annual gain of +25% since 1988. The Zacks Consensus EPS estimate has moved 0.04% higher within the past month. Cardinal Health is currently a Zacks Rank #2 (Buy).
From a valuation perspective, Cardinal Health is currently exchanging hands at a Forward P/E ratio of 20.45. This expresses a premium compared to the average Forward P/E of 15.72 of its industry.
Also, we should mention that CAH has a PEG ratio of 1.36. The PEG ratio is akin to the commonly utilized P/E ratio, but this measure also incorporates the company's anticipated earnings growth rate. As the market closed yesterday, the Medical - Dental Supplies industry was having an average PEG ratio of 1.77.
The Medical - Dental Supplies industry is part of the Medical sector. This group has a Zacks Industry Rank of 68, putting it in the top 28% of all 250+ industries.
The Zacks Industry Rank assesses the strength of our separate industry groups by calculating the average Zacks Rank of the individual stocks contained within the groups. Our research shows that the top 50% rated industries outperform the bottom half by a factor of 2 to 1.
Make sure to utilize Zacks.com to follow all of these stock-moving metrics, and more, in the coming trading sessions.